Neoadjuvant intra-arterial cytoreductive chemo-therapy is used for the treatment of lacrimal
gland adenoid cystic carcinomas (ACC) to improve outcomes in this condition with an …

PURPOSE: To compare the long-term outcomes after intra-arterial cytoreductive
chemotherapy (IACC) with conventional treatment for lacrimal gland adenoid cystic …

Purpose To report the therapeutic efficacy of integrating neoadjuvant chemotherapy with
conventional bimodal therapies for lacrimal gland adenoid cystic carcinoma by providing an …

Background We describe four cases of primary lacrimal adenoid cystic carcinoma (ACC)
treated with neoadjuvant intra-arterial chemotherapy (NAIC). Methods The outcomes and …

PURPOSE: To determine the effect of intraarterial cytoreductive chemotherapy (IACC) as an
adjunct to conventional surgery and radiation therapy for lacrimal gland adenoid cystic …

Purpose: To assess whether exenteration specimens obtained after neoadjuvant intra-
arterial cytoreductive chemotherapy (IACC) for adenoid cystic carcinoma of the lacrimal …

Purpose: To evaluate the efficacy of multimodal treatment in adenoid cystic carcinoma
(ACC) of the lacrimal gland. Methods: A retrospective comparative case series of 40 …

Purpose To determine the effect of intra-arterial cytoreductive chemotherapy (IACC) as an
adjunct of a multimodality protocol for the treatment of lacrimal gland adenoid cystic …

Background Adenoid cystic carcinomas are the most common malignant epithelial tumors of
the lacrimal gland. Their overall incidence is rare, accounting for 1.6% of all orbital tumors. 1 …

Purpose: Lacrimal gland adenoid cystic carcinoma (LGACC) is a rare orbital malignancy
with devastating lethality. Neoadjuvant intra-arterial chemotherapy (IACC) has demonstrated …